Business Wire

PUMA

Share
Conference of the People, Powered by PUMA Puts Gen Z Voices Front and Centre

New research from PUMA, which surveyed 6,000 young people aged 18-25 from the UK, US, France, Germany, Italy and Spain has revealed that 94% of them care about the environment. At the same time, however, almost one in five aren’t motivated to help improve sustainability because the focus is always on older generations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220901005328/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Conference of the People, powered by PUMA, is a first of its kind event which will focus on the voices of Gen Z, as the fashion industry comes together to discuss solutions towards more sustainable processes and practises. (Photo: Business Wire)

The sports company is addressing this focus with Conference of the People, powered by PUMA. The first of its kind event will centre the voices of Gen Z as the fashion industry comes together to discuss solutions towards more sustainable processes and practises. Live from London, streamed to the world on September 6th.

When asked what they would like to see brands doing more of when it comes to environment and sustainability, taking quicker action came out on top (52%). Making more commitments to change what they’re doing came next (49%), followed by communicating their goals better (40%) and being transparent with customers (34%). Two fifths of them are interested in connecting with brands to actively make the change themselves. It once again became clear that young people want brands to listen to their thoughts and opinions on the climate emergency as well. A quarter (26%) of those surveyed do not feel that there is a platform for their generation’s opinions regarding environmental sustainability. The same amount also said they want brands to create platforms to hear from younger generations.

For its one-day event, happening this month, PUMA has compiled panels that will feature some of the most prominent voices in sustainable fashion along with some famous faces that everyone will recognise, as well as next generation thinkers. Topics for discussion include tackling waste, using more sustainable materials, impacting climate change, and finding ways for the industry to collaborate to achieve results sooner.

Eco-anxiety is also on the rise amongst young people. Over a third (36%) of them admitted to feeling very anxious about global warming and the climate emergency. The number is highest in Italy (66%). The sportswear brand plans to tackle this head on. Actress, model, and activist Cara Delevingne will feature in a conversation on how young people can manage the anxieties they’re facing when it comes to the climate crisis.

Conference of the People, powered by PUMA is a first of its kind event. The aim is to create an environment for PUMA’s industry peers, activists, NGOs, experts, ambassadors, and consumers to come together and discuss solutions for some of the fashion industry’s most pressing sustainability challenges. All whilst amplifying the of voices of young people across the world.

Anne-Laure Descours, Chief Sourcing Officer at PUMA says, “With 71% of young people believing that their voices aren’t heard when it comes to environmental sustainability, it’s clear there’s a problem. Gen Z will have to live with climate decisions that are being made today, so we recognise that it’s important that they’re heard in these conversations. My hope is that through Conference of the People, we can give a platform to their voices and create a safe environment for them to collaborate with us, as an industry, on new and better ways of operating.”

To learn more about Conference of the People and to register interest in physical or virtual attendance, users can visit PUMACOP.com and follow @PUMA and [insert local IG if applicable] on social media.

Conference of the People will start on September 6 at 12pm BST (1pm CET, 7 am ET) and the livestream of the event is free to access for all.

PUMA

PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For more than 70 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 16,000 people worldwide, and is headquartered in Herzogenaurach/Germany.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220901005328/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release

- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release

‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye